CERo Therapeutics Warrants
CEROW
CEROW was delisted on the 30th of October, 2025.
30 hedge funds and large institutions have $28K invested in CERo Therapeutics Warrants in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
18.51% more ownership
Funds ownership: 0% → 18.51% (+19%)
12% less funds holding
Funds holding: 34 → 30 (-4)
75% less capital invested
Capital invested by funds: $110K → $28K (-$82.3K)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BOCH
Blue Owl Capital Holdings
New York
|
+$3.73K |
| 2 |
CAC
Cowen and Company
New York
|
+$832 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$2 |
| 4 |
CS
Clear Street
New York
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$5.38K |
| 2 |
KL
KIM LLC
Wichita,
Kansas
|
-$1K |
| 3 |
EAM
Exos Asset Management
New York
|
-$74 |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$35 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SRF
26
Silver Rock Financial
Los Angeles,
California
| $62 | – | – | – |
|
|
AA
27
Ancora Advisors
Cleveland,
Ohio
| $13 | – | – | – |
|
|
28
Bank of America
Charlotte,
North Carolina
| $4 | +$2 | +100 | +14% |
|
|
RCM
29
Robinson Capital Management
Grosse Pointe Farms,
Michigan
| $3 | – | – | – |
|
|
PA
30
Pineridge Advisors
St. Charles,
Missouri
| $1 | – | – | – |
|
|
SCM
31
Shaolin Capital Management
Miami,
Florida
| – | -$5.38K | -267,599 | Closed |
|
|
KL
32
KIM LLC
Wichita,
Kansas
| – | -$1K | -50,000 | Closed |
|
|
EAM
33
Exos Asset Management
New York
| – | -$74 | -3,700 | Closed |
|
CEROW Hedge Fund Activity: Q3 2024 in Review
30 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q3 2024, worth a combined $28K — down 75% from $110K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CEROW and 1 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was Blue Owl Capital Holdings, opening a new position worth an estimated $3.73K. The largest seller was Shaolin Capital Management, exiting entirely with an estimated $5.38K sold.
- 30 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q3 2024, down from 34 in Q2 2024.
- Funds reported $28K of CERo Therapeutics Warrants stock for Q3 2024, down 75% quarter-over-quarter.
- 1 fund opened new CERo Therapeutics Warrants positions in Q3 2024 and 4 closed out, a net change of -3 holders.
- The largest CERo Therapeutics Warrants buyer in Q3 2024 was Blue Owl Capital Holdings, an estimated $3.73K added.
- The largest CERo Therapeutics Warrants seller in Q3 2024 was Shaolin Capital Management, an estimated $5.38K sold.
Based on aggregated 13F filings for Q3 2024.